News

TwoStep Therapeutics Selected to Join Johnson & Johnson’s Global Incubator Network “JLABS”

TwoStep Therapeutics Unveils Its Lead Tumor-Targeted Drug Conjugate and New Radiopharmaceutical Program at Debut Scientific Presentation

J&J’s JLABS Company Spotlight on TwoStep Therapeutics

Bertozzi’s TwoStep Therapeutics to Target Solid Tumors With Engineered Peptide Drug Delivery Vehicle

TwoStep Therapeutics Launches with Funding to Advance Broadly Applicable Targeting Platform for Solid Tumors

New cancer biotech emerges from Stanford research, with help of Nobel laureate Carolyn Bertozzi